Clinical Trial Results

What is COMP?
COMP (Cartilage Oligomeric Matrix Protein) is a marker of cartilage breakdown. Elevated serum COMP levels not only indicate cartilage erosion, but predict future erosion that leads to osteo-arthritis. Recently, joint researchers have focused their attention on the therapeutically lowering COMP levels. BioSil ON YOUR GAME’s ch-OSA is clinically proven to lower COMP levels a full 2% in just 12 weeks, trending towards additional lowering. Compare that to the Placebo group where COMP rose 17%.